Showing results (631-640 of 656) with videos related to

Sort By:
Pageof 66
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 12, 2023
Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancerHarkeran K Jandu, Colin D Veal, Laura Fachal, et al.
Nature Microbiology|September 22, 2020
Discovery of broad-spectrum fungicides that block septin-dependent infection processes of pathogenic fungiMin He, Jia Su, Youpin Xu, et al.
Pediatrics|January 28, 2021
Appendectomy Versus Observation for Appendicitis in Neutropenic Children With CancerBenjamin T Many, Timothy B Lautz, Sarah Dobrozsi, et al.
Breast (Edinburgh, Scotland)|June 26, 2025
Integrating genetic polymorphisms and clinical data to develop predictive models for skin toxicity in breast cancer radiation therapyEster Aguado-Flor, Victoria M Reyes, Víctor Navarro, et al.
Nature Genetics|October 3, 2006
Mutations in FRMD7, a newly identified member of the FERM family, cause X-linked idiopathic congenital nystagmusPatrick Tarpey, Shery Thomas, Nagini Sarvananthan, et al.
Science (New York, N.Y.)|December 12, 2024
Confronting risks of mirror lifeKatarzyna P Adamala, Deepa Agashe, Yasmine Belkaid, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 4, 2022
The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE studyLotte van der Weijst, David Azria, Patrick Berkovic, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 10, 2021
Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicityNicola Rares Franco, Michela Carlotta Massi, Francesca Ieva, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 25, 2022
Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancerSarah L Kerns, Ashley Amidon Morlang, Sharon M Lee, et al.
Pageof 66